recent fda approvals for multiple myeloma and what to expect from treatments in development
Published 3 years ago • 585 plays • Length 9:53Download video MP4
Download video MP3
Similar videos
-
0:37
j&j’s carvykti and bms’ abecma win fda approvals for earlier use in multiple myeloma
-
3:26
what does the fda approval of mrd testing for myeloma mean for patients and drug development?
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
3:28
fda expected to approve new multiple myeloma treatment
-
58:19
sequencing bcma myeloma therapies
-
4:25
what new drug options will be available for patients with relapsed and refractory myeloma in 2020?
-
20:12
personalized medicine in multiple myeloma: the latest treatment advancements
-
3:47
fda approves blood test for colorectal cancer screening for some adults
-
24:22
highlight of cll-related 2016 fda approvals: venetoclax
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
35:13
reaching the next level of myeloma patient care: antibody therapy and novel mechanisms of action
-
1:07:49
watch the experts discuss the latest multiple myeloma updates: https://bit.ly/3swv3qu
-
44:53
update in multiple myeloma
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
6:35
ash impact series: vincent rajkumar, md - examining the new fda approved myeloma drug products
-
0:37
fda advisory committee backs carvykti and abecma for earlier myeloma treatment
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
6:11
fda labels of new multiple myeloma agents
-
6:17
ash impact series: paul richardson, md - examining the new fda approved myeloma drug products